Yuting Zhuang
P.R. China
Harbin, China
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SPOP Is a Key Trigger of Pathological Cardiac Hypertrophy and Heart Failure.
Journal: Circulation research
Published: September 15, 2025
Effective Dose Reduction of Emamectin Benzoate Through Inhibition of Bx-SDR3 in Pine Wood Nematode Management.
Journal: International journal of molecular sciences
Published: January 16, 2025
Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarction.
Journal: Cell chemical biology
Published: November 24, 2022
LncRNA-H19 Drives Cardiomyocyte Senescence by Targeting miR-19a/socs1/p53 Axis.
Journal: Frontiers in pharmacology
Published: November 21, 2020
LncRNA ACART protects cardiomyocytes from apoptosis by activating PPAR-γ/Bcl-2 pathway.
Journal: Journal of cellular and molecular medicine
Published: April 24, 2019
Involvement of lncR-30245 in Myocardial Infarction-Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ-Mediated Connective Tissue Growth Factor Signalling Pathway.
Journal: The Canadian journal of cardiology
Published: February 06, 2019
LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca2+ Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction.
Journal: Circulation research
Published: September 24, 2017
Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.
Journal: Oncotarget
Published: November 30, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026